Results 181 to 190 of about 5,850,068 (304)

Prediction of Prevalent Cardiovascular Disease Using Social, Environmental, and Behavioral Factors: A Vital Conditions Framework Approach

Chronic Diseases and Translational Medicine, EarlyView.
The Vital Conditions Framework. Graphical representation of the Vital Conditions for Health Framework with seven domains. Images used with permission from The Rippel Foundation: An Introduction to the Vital Conditions for Health and Well‐Being. https://rippel.org/events/webinar-an-introduction-to-the-vital-conditions-for-health-and-well-being/. Federal
Stephanie Kjelstrom, Richard Hass, Robert Vollbrecht, Brandon George, Sharon Larson   +4 more
wiley   +1 more source

Short‐Term Effects of Golden Rice Cookies Enriched With Piper crocatum Extract on Lipid Profiles in Adults With Diabetes: A Quasi‐Experimental Study

Chronic Diseases and Translational Medicine, EarlyView.
ABSTRACT Background Diabetes mellitus (DM) commonly coexists with dyslipidemia and elevated cardiovascular risk. Food‐based interventions containing antioxidants and polyphenols may support lipid metabolism. This study evaluated the short‐term effects of Golden Rice cookies enriched with active Piper crocatum extract on lipid profiles in adults with DM.
Altje Suwardi Abram, Andina Setyawati, Andi Masyitha Irwan   +2 more
wiley   +1 more source

Reply to the Letter to the Editor: "Remarkable Indices in Predicting Atherosclerotic Cardiovascular Disease". [PDF]

Anatol J Cardiol
Song X, Lin X, Xu X, He Y.
europepmc   +1 more source

Triglyceride Polygenic Score Identifies Individuals Who May Respond Differently to Aspirin in Primary Prevention

Clinical Pharmacology &Therapeutics, EarlyView.
Low‐dose aspirin is no longer routinely recommended for the primary prevention of cardiovascular disease in older adults due to a lack of net benefit over bleeding risk. We hypothesized that genetic subgroups may experience differential harm or benefit from aspirin therapy.
Peter D. Fransquet, Chenglong Yu, Cammie Tran, Sultana Monira Hussain, Chad A. Bousman, Mark R. Nelson, Andrew M. Tonkin, John J. McNeil, Paul Lacaze   +8 more
wiley   +1 more source

Remarkable Indices in Predicting Atherosclerotic Cardiovascular Disease. [PDF]

Anatol J Cardiol
Kaya Ç, Gürdoğan M.
europepmc   +1 more source

Systemic aging fuels heart failure: Molecular mechanisms and therapeutic avenues

ESC Heart Failure, Volume 12, Issue 2, Page 1059-1080, April 2025.
Abstract Systemic aging influences various physiological processes and contributes to structural and functional decline in cardiac tissue. These alterations include an increased incidence of left ventricular hypertrophy, a decline in left ventricular diastolic function, left atrial dilation, atrial fibrillation, myocardial fibrosis and cardiac ...
Zhuyubing Fang, Umar Raza, Jia Song, Junyan Lu, Shun Yao, Xiaohong Liu, Wei Zhang, Shujuan Li   +7 more
wiley   +1 more source

Prediction of incident heart failure in established atherosclerotic cardiovascular disease: the SMART2-HF model. [PDF]

Eur Heart J
Reitsma TH, Lim CE, Gynnild MN, Kaptoge S, Lõo L, Holtrop J, Kuźma Ł, Pennells L, Conrad N, Ueda P, Jernberg T, Kurasz A, Keene SJ, Chilala C, Deo SV, Tillmann T, Khunti K, Piepoli M, Rossello X, Savarese G, Dalen H, Steg PG, Wood AM, Lees JS, Kavousi M, McEvoy JW, de Boer RA, Andersson C, Bhatt DL, Visseren FLJ, Dorresteijn JAN, Koudstaal S, Di Angelantonio E, Hageman SHJ, UCC-SMART study group & the ESC Cardiovascular Risk Collaboration .   +34 more
europepmc   +1 more source

Association of COPD with adverse outcomes in heart failure patients with preserved ejection fraction

ESC Heart Failure, Volume 12, Issue 2, Page 799-808, April 2025.
Abstract We performed a systematic review and meta‐analysis to detect the impact of chronic obstructive pulmonary disease (COPD) on the prognosis of heart failure patients with preserved ejection fraction (HFpEF). We systematically screened eligible literature from three electronic databases, PubMed, EMBASE and Cochrane Library, up to April 2023.
Shuo Xu, Zhenbang Gu, Wengen Zhu, Shenghui Feng   +3 more
wiley   +1 more source

Hypertriglyceridaemia and its multifaceted mechanisms driving atherosclerotic cardiovascular disease​​. [PDF]

Lipids Health Dis
Li X, Xu L, Li J, Luo Y, Shen H, Zhang D.   +5 more
europepmc   +1 more source

Gut microbiota‐related modulation of immune mechanisms in post‐infarction remodelling and heart failure

ESC Heart Failure, Volume 12, Issue 2, Page 942-954, April 2025.
Abstract The immune system has long been recognized as a key driver in the progression of heart failure (HF). However, clinical trials targeting immune effectors have consistently failed to improve patient outcome across different HF aetiologies. The activation of the immune system in HF is complex, involving a broad network of pro‐inflammatory and ...
Johann Roessler, Friederike Zimmermann, Bettina Heidecker, Ulf Landmesser, Arash Haghikia   +4 more
wiley   +1 more source